Genetesis
PrivateLast Round
Series C
Oct 6, 2022
Total Funding Raised
$35.74M
Company Overview
Genetesis, Inc. is a commercial-stage medical technology company founded in 2013 and based in Mason, Ohio. The company is focused on improving the diagnosis of myocardial ischemia and coronary artery disease. Its flagship product is the CardioFlux platform, a non-invasive biomagnetic imaging technology that measures the natural magnetic fields produced by the heart's electrical activity. This technology, an evolution of magnetocardiography (MCG), aims to provide a rapid, radiation-free, and patient-centric diagnostic test for cardiac conditions in settings like the emergency room. The CardioFlux system works in conjunction with the Faraday Analytical Cloud (FAC), a proprietary cloud-based service for data analysis and workflow integration. Genetesis has raised over $40 million in funding, with its latest Series C round in October 2022. The company has received FDA 510(k) clearance for CardioFlux and has also been granted Breakthrough Device Designation by the FDA.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Healthcare Analytics, Health IoT
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genetesis Comps
Public and private peers based on sector, stage, and business model.
Genetesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 6, 2022 | ||||
| Accelerator | Oct 18, 2021 | ||||
| Series B | May 7, 2020 | ||||
| Series A | Jun 5, 2018 | ||||
| Seed | Nov 14, 2016 | ||||
Accelerator | Oct 30, 2014 |
Key People
Founding team and executive leadership
Genetesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Radical Investments | Series A, Seed |
| CincyTech | Series C, Series B, Seed, Series A |
| The Raptor Group | Series A |
| Yard Ventures | Accelerator |
| Cercano Management | Series C |
| TDK Ventures | Series B |
| HealthTech Arkansas | Accelerator |
Genetesis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Genetesis's valuation, stock price, and market status.
